Industry

Application based on Phase 3 TRANSFORM study in which Breyanzi outperformed the current standard of care with demonstrated statistically significant improvement in event-free survival and a well-established safety profile PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #Bcell—Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated its type II variation application for extension of … [Read more…]

RALEIGH, N.C.–(BUSINESS WIRE)–Phreesia is proud to announce that Hilary Hatch, PhD, the company’s Chief Clinical Officer, has been selected to participate in the National Quality Forum (NQF)’s 2022 Leadership Consortium. Dr. Hatch’s inclusion in this expert group underscores Phreesia’s commitment to improving patients’ healthcare experiences and outcomes by enabling them to become more active participants … [Read more…]

Offers flexibility in blood collection tube choice enabling cost-effective workflows in non-invasive prenatal testing Scalable and precise DNA size selection reduces no-call rates for improved patient outcomes MANCHESTER, England–(BUSINESS WIRE)–Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, announces today the launch of the LightBench® Detect, the latest addition to its Ranger® … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–#AndrewQueen–Integrated Dermatology, one of the nation’s largest providers of dermatology services, has expanded its South Florida network by partnering with Kenneth A. Rosen, M.D. Dermatology in Miami. The practice, which includes offices in Kendall and Miami Lakes, offers patients general dermatological care and cosmetic procedures. Dr. Rosen is an experienced, board-certified dermatologist … [Read more…]

Dxcover® Infrared Platform enables high-speed, low-cost, and sensitive early detection of multiple cancers DUBLIN–(BUSINESS WIRE)–Dxcover Limited, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the launch of the Dxcover® platform, a ground-breaking platform that transforms Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy to enable … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pulmonary Sarcoidosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Pulmonary Sarcoidosis, historical and forecasted epidemiology as well as the Pulmonary Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. … [Read more…]

VIENNA–(BUSINESS WIRE)–#MPN–AOP Health announced the final results on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from its CONTINUATION-PV study in an oral presentation at the prestigious EHA (European Hematology Association) 2022 Annual Meeting by Professor Heinz Gisslinger, Medical University of Vienna, Austria 1. Link to abstract Ropeginterferon alfa-2b is a long-acting, mono-pegylated proline interferon … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “6-Hour Virtual Seminar on Biostatistics for the Non-Statistician” webinar has been added to ResearchAndMarkets.com’s offering. The use of statistics in clinical trials ensures a valid and robust study that minimizes bias in assessing the efficacy of new drug treatments or medical devices. Participants in this 6-hour virtual seminar will learn the fundamentals of … [Read more…]

Continuous monitoring using wearable sensors in general hospital wards may help detect patient deterioration earlier than traditional spot check methods and assist clinicians in improving patient outcomes1. Wireless monitoring allows earlier patient mobilization, a key indicator for recovery, particularly post-surgery2. This innovative technology was developed at GE Healthcare’s global center of excellence for monitoring solutions … [Read more…]

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Kinarus showed antiviral efficacy of KIN001 against SARS-CoV-2 and its variants of concern in vitro Interim data in Q3 for KINETIC, Phase 2 trial of KIN001 in hospitalized COVID-19 patients KINFAST Phase 2 trial of KIN001 in ambulatory COVID-19 patients to start this summer BASEL, Switzerland–(BUSINESS WIRE)–Kinarus Therapeutics Holding AG … [Read more…]